Drug ID: | NPD6421 |
Drug Name: | LAF-389 |
Molecular Formula: | C25H42N2O8 |
Canonical SMILES: | CO[C@H]([C@@H]([C@H]([C@@H](/C=C/C(C)(C)C)O)O)O)C(=N[C@H]1CC[C@H](CN=C1O)OC(=O)C1CCCCC1)O |
Standard InCHI: | InChI=1S/C25H42N2O8/c1-25(2,3)13-12-18(28)19(29)20(30)21(34-4)23(32)27-17-11-10-16(14-26-22(17)31)35-24(33)15-8-6-5-7-9-15/h12-13,15-21,28-30H,5-11,14H2,1-4H3,(H,26,31)(H,27,32)/b13-12+/t16-,17+,18-,19+,20-,21-/m1/s1 |
Standard InCHIKey: | XSYJUVKQRPLTAU-BKMGADMVSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB002288 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 498.29 |
ALogP | -1.4649 |
MLogP | 3.11 |
XLogP | 2.224 |
HDA | 10 |
HBD | 5 |
Rotatable Bonds | 20 |
TPSA | 161.4 |
RO5 Violation | 1 |